...
首页> 外文期刊>Journal of minimal access surgery >Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients. Feasibility of nonanatomic resection in difficult tumor locations
【24h】

Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients. Feasibility of nonanatomic resection in difficult tumor locations

机译:腹腔镜肝切除术治疗肝硬化患者的肝细胞癌。在难于肿瘤的部位进行非解剖切除的可行性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Surgical resection for hepatocellular carcinoma (HCC) in cirrhotic patients remains controversial because of high morbidity and recurrence rates. Laparoscopic resection of liver tumors has recently been developed and could reduce morbidity. The aim of this study was to evaluate retrospectively our results for laparoscopic liver resection (LLR) for HCC including lesions in the posterosuperior segments of the liver in terms of feasibility, outcome, recurrence and survival.MATERIALS AND METHODS:Between June 2005 and February 2009, we performed 20 LLR for HCC. Median age of the patients was 66 years. The underlying cirrhosis was staged as Child A in 17 cases and Child B in 3.RESULTS:LLR included anatomic resection in six cases and nonanatomic resection in 14. Eleven procedures were associated in nine (45%) patients. Median tumor size and surgical margins were 3.1 cm and 15 mm, respectively. A conversion to laparotomy occurred in one (5%) patient for hemorrhage. Mortality and morbidity rates were 0% and 15% (3/20). Median hospital stay was 8 days (range: 5-16 days). Over a mean follow-up period of 26 months (range: 19–62 months), 10 (50%) patients presented recurrence, mainly at distance from the surgical site. Treatment of recurrence was possible in all the patients, including orthotopic liver transplantation in three cases.CONCLUSIONS:LLR for HCC in selected patients is a safe procedure with good short-term results. It can also be proposed in tumor locations with a difficult surgical access maintaining a low morbidity rate and good oncological adequacy. This approach could have an impact on the therapeutic strategy of HCC complicating cirrhosis as a treatment with curative intent or as a bridge to liver transplantation.
机译:背景:由于高发病率和复发率,肝硬化患者的肝癌手术切除仍存在争议。腹腔镜切除肝脏肿瘤最近已经发展,可以减少发病率。这项研究的目的是回顾性地评估我们的HCC腹腔镜肝切除术(LLR)的结果,包括可行性,结果,复发和生存方面的肝后上段病变。材料与方法:2005年6月至2009年2月,我们为HCC执行了20次LLR。患者的中位年龄为66岁。潜在的肝硬化分17例为儿童A,3例为儿童B。结果:LLR包括6例解剖切除和14例非解剖切除,其中9例(45%)患者进行了11例手术。中位肿瘤大小和手术切缘分别为3.1 cm和15 mm。一名(5%)出血患者转为剖腹手术。死亡率和发病率分别为0%和15%(3/20)。中位住院天数为8天(范围:5-16天)。在平均26个月的随访期内(19-62个月),有10例(50%)患者复发,主要是在距手术部位较远的地方。所有患者均可以治疗复发,包括三例原位肝移植。结论:LLR在部分患者中进行肝癌治疗是一种安全的方法,短期效果良好。也可以在难以手术进入的肿瘤部位提出,以保持较低的发病率和良好的肿瘤学适应性。这种方法可能对具有治愈目的的肝癌或肝移植的桥梁,对肝硬化并发肝癌的治疗策略产生影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号